Zoe Innovations is a veteran-owned biotechnology company, involved in both basic and clinical research and development of stem cells and other biologic products for human and veterinary markets, as well as for the new drug discovery/investigational new drug/clinical trials market. Our research includes the use of genomics and epigenetics to revolutionize regenerative treatments.

Mission Statement:

To meet the need of clinicians and researchers for quality biologic products and to further epigenetically driven regenerative research for the betterment of humanity.

Product/Service:

We will soon have the capacity to supply a reliable volume of high quality stem cells for the international community. Our research focuses on identifying which patients will benefit from specific biologic treatments and providing personalized regenerative protocols for the treatment of difficult to treat diseases.

Market Size:

There is a growing international need. The global stem cell market is expected to grow from $10.2 billion in 2021 to $20.87 billion in 2025.

Sales/Marketing Strategy:

We have partnered with a leading marketing company and will also have representation at medical and government conferences. Our sales team will focus on sales to reputable researchers and clinicians worldwide.

Target Market:

International medical clinics and researchers including academia, government, and private sector.

Financial Information:

Zoe Innovations has secured $5 milllion in seed funding.

Business/Revenue Model:

Domestic and international biologics sales, as well as research and joint ventures focused on intellectual property development and application.

Competitive Advantage:

Our full-time team is composed of experienced experts in the stem cell and biotech space. With our planned capacity, we hope to provide high quality cells at competitive rates. We also hope to become the leader in addressing the patient-specific needs of researchers with epigenetically driven therapies.